HeartPatch

Device allows for conditioning and characterization of myocardial cell sheets for improved incorporation and enhanced cardiac function upon implantation.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded February 2018
  • Employees 2
  • Incorporation Type Not Incorporated

Company Summary

Cardiovascular disease patients would benefit from surgical treatment with HeartPatch, a cell sheet patch designed to replace damaged myocardium with functioning engineered heart tissue. Our bio-MEMS platform characterizes the functional properties of patches and conditions them to have conduction velocity and contractility compatible with the patient's resident heart tissue for improved incorporation and resulting cardiac function.

Team

  • Erin Roberts

    PhD, 8+ years of industrial and R&D experience
    2010-2012. General Electric Energy. Product design for gas turbines, air filtration, and gasification.
    2012-present. Graduate student in Materials Science and Engineering at Boston University.
    2014-present. Boston Children’s Hospital. Tissue engineering, surgical implant and tool design.

  • Vladimir Kleptsyn

    PhD, 30+ years R&D experience
    -Boston University Electronics & Circuit Instructional Lab: Professional Management for 15 years, 5-8 part-time employees. More than 400 College of Engineering students yearly.
    -Start-up and Business Experience:
    2004-2009. Start-up company was established for developing a high-tech material for optical applications.
    2008-current. Consults start-up companies and deeply involved in R&D as researcher/vendor/engineer.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free